Exubera Approval History
FDA Approved: Yes (Discontinued) (First approved January 27, 2006)
Brand name: Exubera
Generic name: insulin inhalation
Dosage form: Powder
Company: Pfizer Inc.
Treatment for: Diabetes, Type 1, Diabetes, Type 2
Marketing Status: Discontinued
Exubera is a rapid-acting, dry powder human insulin inhalation indicated for the treatment of adult patients with diabetes mellitus, either as monotherapy, or in combination with oral agents or longer-acting insulins.
Development History and FDA Approval Process for Exubera
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.